Another GLP-1 drug is up for Medicare negotiations under the Inflation Reduction Act.
Eli Lilly’s diabetes drug Trulicity is among 15 drugs selected for the third round of negotiations. For the first time, CMS has …
AstraZeneca, already one of the leading pharmaceutical companies in China, is extending its reach in the country that’s become a go-to place for drug R&D
Two companies that run on-site health clinics for employers like Google and Amazon are merging as healthcare costs continue to climb. Advanced primary care company
With two positive clinical readouts in the bag, a US approval filing, and another important trial due to report in a couple months, Roche’s breast
The French biotech Abivax was a biotech market standout for 2025. Formation Bio now wants a piece of that success. The privately-held New York pharma
Sanofi says it will be able to spend between €14 billion and €15 billion on M&A deals this year while still being able to meet
Another GLP-1 drug is up for Medicare negotiations under the Inflation Reduction Act.
Eli Lilly’s diabetes drug Trulicity is among 15 drugs selected for the third round of negotiations. For the first time, CMS has …